Five Star Equities Issues New Research Reports on CYNI, NBIX, OREX and PLUG - KTEN.com - No One Gets You Closer

Five Star Equities Issues New Research Reports on CYNI, NBIX, OREX and PLUG

Posted: Updated:

Five Star Equities releases regular market updates so investors can stay ahead of the crowd and make the best investment decisions to maximize their returns. Take a few minutes to register with us free at www.FiveStarEquities.com and get exclusive access to our numerous stock reports.

Cyan Inc. (NYSE: CYNI) shares dropped 29.79 percent to close at $3.63 a share Tuesday. The stock traded between $3.60 and $4.05 on volume 3.83 million shares traded. The company announced that it expects revenue for the fourth quarter of 2013 to be in the range of $20.0 million to $21.0 million, down from its previous guidance of $30.0 million to $33.0 million. Shares of Cyan have fallen approximately 65.0 percent in the past year.

Get more information on Cyan free access to the in-depth equity report at:
www.FiveStarEquities.com/CYNI

Neurocrine Biosciences, Inc. (NASDAQ: NBIX) shares soared 89.69 percent to close at $18.51 a share Tuesday. The stock traded between $15.20 and $18.62 on volume of 18.95 million shares traded. The company reported positive results from a Phase II study of NBI-98854 for the treatment of tardive dyskinesia. Shares of Neurocrine Biosciences have gained approximately 120.0 percent in the past year.

Get more information on Neurocrine Biosciences and free access to the in-depth equity report at:
www.FiveStarEquities.com/NBIX

Orexigen Therapeutics, Inc. (NASDAQ: OREX) shares increased 2.65 percent to close at $5.82 a share Tuesday. The stock traded between $5.48 and $5.82 on volume 3.98 million shares traded. The company announced that the FDA has set a Prescription Drug User Fee Act goal date of June 10, 2014 for Contrave. Shares of Orexigen Therapeutics have fallen approximately 3.0 percent in the past year.

Get more information on Orexigen Therapeutics free access to the in-depth equity report at:
www.FiveStarEquities.com/OREX

Plug Power Inc. (NASDAQ: PLUG) shares surged 38.99 percent to close at $3.85 a share Tuesday. The stock traded between $3.05 and $4.14 on volume 122.05 million shares traded. The company announced that it will develop hydrogen fuel cell range extenders for 20 FedEx Express electric delivery trucks. Shares of Plug Power have gained approximately 625.0 percent in the past year.

Get more information on Plug Power and free access to the in-depth equity report at:
www.FiveStarEquities.com/PLUG

Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor’s reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Five Star Equities has no financial relationship with any company whose stock is mentioned in this release.

Contact:
Five Star Equities
info@fivestarequities.com

Source: http://www.accesswire.com/viewarticle.aspx?id=410813

ReleaseID: 30418